[
  {
    "ts": "2025-10-17T21:45:05+00:00",
    "headline": "CVS Health (CVS) Outpaces Stock Market Gains: What You Should Know",
    "summary": "CVS Health (CVS) closed at $82.52 in the latest trading session, marking a +1.41% move from the prior day.",
    "url": "https://finance.yahoo.com/news/cvs-health-cvs-outpaces-stock-214505976.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "d7152cc0-da8a-3f96-9cce-f597827b355d",
      "content": {
        "id": "d7152cc0-da8a-3f96-9cce-f597827b355d",
        "contentType": "STORY",
        "title": "CVS Health (CVS) Outpaces Stock Market Gains: What You Should Know",
        "description": "",
        "summary": "CVS Health (CVS) closed at $82.52 in the latest trading session, marking a +1.41% move from the prior day.",
        "pubDate": "2025-10-17T21:45:05Z",
        "displayTime": "2025-10-17T21:45:05Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/7853de8d69faeccb7d1ad6ebba40b8a2",
          "originalWidth": 900,
          "originalHeight": 741,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/EYdBVn9rFNc9AepqcsmXXg--~B/aD03NDE7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/7853de8d69faeccb7d1ad6ebba40b8a2.cf.webp",
              "width": 900,
              "height": 741,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/UC8YVzs0fyygH41RFBV7Qg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/7853de8d69faeccb7d1ad6ebba40b8a2.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/cvs-health-cvs-outpaces-stock-214505976.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/cvs-health-cvs-outpaces-stock-214505976.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "CVS"
            },
            {
              "symbol": "^SPX"
            },
            {
              "symbol": "^DJI"
            },
            {
              "symbol": "^IXIC"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-10-17T19:14:05+00:00",
    "headline": "Medicare Part D plans: Expert reveals that 95% of beneficiaries are overspending on prescriptions",
    "summary": "Nearly all 55 million Medicare users overpay for prescriptions. Expert Katy Votava explains how to compare Part D plans and save thousands.",
    "url": "https://finance.yahoo.com/news/medicare-part-d-plans-expert-reveals-that-95-of-beneficiaries-are-overspending-on-prescriptions-191405414.html",
    "source": "Yahoo Finance",
    "provider": "yfinance",
    "raw": {
      "id": "6587b1c2-ca90-4518-a3e4-7a85645351e8",
      "content": {
        "id": "6587b1c2-ca90-4518-a3e4-7a85645351e8",
        "contentType": "STORY",
        "title": "Medicare Part D plans: Expert reveals that 95% of beneficiaries are overspending on prescriptions",
        "description": "",
        "summary": "Nearly all 55 million Medicare users overpay for prescriptions. Expert Katy Votava explains how to compare Part D plans and save thousands.",
        "pubDate": "2025-10-17T19:14:05Z",
        "displayTime": "2025-10-17T19:14:05Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://s.yimg.com/os/creatr-uploaded-images/2025-10/6cf54060-aab5-11f0-aff9-0cb189e1520e",
          "originalWidth": 5000,
          "originalHeight": 3333,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/vPXx8dOp4vdP7EGmwaA_9Q--~B/aD0zMzMzO3c9NTAwMDthcHBpZD15dGFjaHlvbg--/https://s.yimg.com/os/creatr-uploaded-images/2025-10/6cf54060-aab5-11f0-aff9-0cb189e1520e.cf.webp",
              "width": 5000,
              "height": 3333,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/osWg71lr_wwPxhsuOuO6Xw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://s.yimg.com/os/creatr-uploaded-images/2025-10/6cf54060-aab5-11f0-aff9-0cb189e1520e.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Yahoo Finance",
          "url": "http://finance.yahoo.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/medicare-part-d-plans-expert-reveals-that-95-of-beneficiaries-are-overspending-on-prescriptions-191405414.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/medicare-part-d-plans-expert-reveals-that-95-of-beneficiaries-are-overspending-on-prescriptions-191405414.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "UNH"
            },
            {
              "symbol": "CVS"
            },
            {
              "symbol": "CNC"
            },
            {
              "symbol": "HUM"
            },
            {
              "symbol": "CI"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-10-17T15:15:00+00:00",
    "headline": "Here's Why Realty Income's Focus on Essential Retail Keeps It Steady",
    "summary": "O's focus on non-discretionary tenants drives steady cash flow and keeps its portfolio nearly full even in uncertain markets.",
    "url": "https://finance.yahoo.com/news/heres-why-realty-incomes-focus-151500346.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "8d0f17dd-fb11-3168-9223-28102d787ab6",
      "content": {
        "id": "8d0f17dd-fb11-3168-9223-28102d787ab6",
        "contentType": "STORY",
        "title": "Here's Why Realty Income's Focus on Essential Retail Keeps It Steady",
        "description": "",
        "summary": "O's focus on non-discretionary tenants drives steady cash flow and keeps its portfolio nearly full even in uncertain markets.",
        "pubDate": "2025-10-17T15:15:00Z",
        "displayTime": "2025-10-17T15:15:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/3ad5e0e8e428dd3de2c59bd91ad11b86",
          "originalWidth": 620,
          "originalHeight": 413,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/7J.X32Zzmc2W3SsZuKEKkQ--~B/aD00MTM7dz02MjA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/3ad5e0e8e428dd3de2c59bd91ad11b86.cf.webp",
              "width": 620,
              "height": 413,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/4EImc3SxFDH3MHGXlWoHqg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/3ad5e0e8e428dd3de2c59bd91ad11b86.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/heres-why-realty-incomes-focus-151500346.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/heres-why-realty-incomes-focus-151500346.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "KIM"
            },
            {
              "symbol": "KIM-PL"
            },
            {
              "symbol": "KIM-PM"
            },
            {
              "symbol": "KIM-PN"
            },
            {
              "symbol": "O"
            },
            {
              "symbol": "DG"
            },
            {
              "symbol": "CVS"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-10-17T14:18:00+00:00",
    "headline": "Danaher Gears Up to Post Q3 Earnings: What Lies Ahead for the Stock?",
    "summary": "DHR gears up for Q3 results with steady earnings estimates and mixed segment trends across Life Sciences, Biotechnology and Diagnostics.",
    "url": "https://finance.yahoo.com/news/danaher-gears-post-q3-earnings-141800555.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "acfb60ed-24cb-39ef-8471-0131858650e0",
      "content": {
        "id": "acfb60ed-24cb-39ef-8471-0131858650e0",
        "contentType": "STORY",
        "title": "Danaher Gears Up to Post Q3 Earnings: What Lies Ahead for the Stock?",
        "description": "",
        "summary": "DHR gears up for Q3 results with steady earnings estimates and mixed segment trends across Life Sciences, Biotechnology and Diagnostics.",
        "pubDate": "2025-10-17T14:18:00Z",
        "displayTime": "2025-10-17T14:18:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/9c1d11cd27737fac4805145de6e5eee0",
          "originalWidth": 635,
          "originalHeight": 400,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/TNBAnrhWOnvvvNSvMEIuFg--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/9c1d11cd27737fac4805145de6e5eee0.cf.webp",
              "width": 635,
              "height": 400,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/rP7ZEHNft_Sb_FB9M.3i3w--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/9c1d11cd27737fac4805145de6e5eee0.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/danaher-gears-post-q3-earnings-141800555.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/danaher-gears-post-q3-earnings-141800555.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "DHR"
            },
            {
              "symbol": "CVS"
            },
            {
              "symbol": "TDOC"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-10-17T12:37:00+00:00",
    "headline": "CVS Expands Its Nationwide Care Network With Rite Aid Acquisition",
    "summary": "CVS Pharmacy completes the Rite Aid deal, adding 63 stores, 626 pharmacies and nine million patients to its national care network.",
    "url": "https://finance.yahoo.com/news/cvs-expands-nationwide-care-network-123700037.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "f90c1442-00a0-38e3-8d6e-2605b55ae5b2",
      "content": {
        "id": "f90c1442-00a0-38e3-8d6e-2605b55ae5b2",
        "contentType": "STORY",
        "title": "CVS Expands Its Nationwide Care Network With Rite Aid Acquisition",
        "description": "",
        "summary": "CVS Pharmacy completes the Rite Aid deal, adding 63 stores, 626 pharmacies and nine million patients to its national care network.",
        "pubDate": "2025-10-17T12:37:00Z",
        "displayTime": "2025-10-17T12:37:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/afe95824683969079aeba27c8210bd37",
          "originalWidth": 635,
          "originalHeight": 400,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/O2fLjSeGpHAp4pnNFR6egw--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/afe95824683969079aeba27c8210bd37.cf.webp",
              "width": 635,
              "height": 400,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/qPY9mhd4gwuyP0ATgGKKxQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/afe95824683969079aeba27c8210bd37.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/cvs-expands-nationwide-care-network-123700037.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/cvs-expands-nationwide-care-network-123700037.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "UNH"
            },
            {
              "symbol": "CAH"
            },
            {
              "symbol": "CVS"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-10-17T01:40:41+00:00",
    "headline": "CVS Health Corporation (CVS): A Must-Buy Dividend Stock Leading U.S. Pharmacy and Healthcare",
    "summary": "CVS Health Corporation (NYSE:CVS) is included among the 12 Must-Buy Dividend Stocks to Invest in. CVS Health Corporation (NYSE:CVS) st⁠ands among the larg‍est pharmacy and retail chains in the United States, w⁠i‍th a n⁠etwork of over 9,000 pharmacies and⁠ more th‌a‌n 1,000 walk-in clinics. The compa‍ny​’s stoc⁠k has per‍formed strongly th‍is year,‍ cl‌imbi‌ng 33% in […]",
    "url": "https://finance.yahoo.com/news/cvs-health-corporation-cvs-must-014041752.html",
    "source": "Insider Monkey",
    "provider": "yfinance",
    "raw": {
      "id": "75ad94f4-6cd3-3826-ac92-88098cfddf80",
      "content": {
        "id": "75ad94f4-6cd3-3826-ac92-88098cfddf80",
        "contentType": "STORY",
        "title": "CVS Health Corporation (CVS): A Must-Buy Dividend Stock Leading U.S. Pharmacy and Healthcare",
        "description": "",
        "summary": "CVS Health Corporation (NYSE:CVS) is included among the 12 Must-Buy Dividend Stocks to Invest in. CVS Health Corporation (NYSE:CVS) st⁠ands among the larg‍est pharmacy and retail chains in the United States, w⁠i‍th a n⁠etwork of over 9,000 pharmacies and⁠ more th‌a‌n 1,000 walk-in clinics. The compa‍ny​’s stoc⁠k has per‍formed strongly th‍is year,‍ cl‌imbi‌ng 33% in […]",
        "pubDate": "2025-10-17T01:40:41Z",
        "displayTime": "2025-10-17T01:40:41Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/insidermonkey.com/4e33e0d1a07889115aefcb74e0ea299f",
          "originalWidth": 1456,
          "originalHeight": 816,
          "caption": "CVS Health Corporation (CVS): A Must-Buy Dividend Stock Leading U.S. Pharmacy and Healthcare",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/yrDm7iyVNAagx0oOilifnQ--~B/aD04MTY7dz0xNDU2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/insidermonkey.com/4e33e0d1a07889115aefcb74e0ea299f.cf.webp",
              "width": 1456,
              "height": 816,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/Q.L_4QVhEk8dUSgrDa_Iag--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/4e33e0d1a07889115aefcb74e0ea299f.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Insider Monkey",
          "url": "http://www.insidermonkey.com"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/cvs-health-corporation-cvs-must-014041752.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/cvs-health-corporation-cvs-must-014041752.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "CVS"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]